Redirecting to https://www.globenewswire.com/news-release/2025/12/10/3203016/0/en/BlossomHill-Therapeutics-Announces-84-Million-Financing-to-Accelerate-Clinical-Stage-Pipeline-of-Intelligently-Designed-Cancer-Medicines-Including-First-in-class-Macrocyclic-OMNI-E.html